NETA’s parent company, Parallel, just approved $3 million for research medical effects of cannabis on diseases like Sickle Cell

8/6/20–Parallel, which owns NETA, has approved $3 million in grants to aid in medical research of cannabis. The grant money will be used to partner with the University of Pittsburg for a 10-year study researching the effects of medical cannabis. Read